Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1978 Apr;75(4):2011–2015. doi: 10.1073/pnas.75.4.2011

Differences in behavior and prognosis between leukemic and lymphomatous forms of a transplantable hamster lymphocytic neoplasm induced by simian virus 40.

G T Diamandopoulos
PMCID: PMC392473  PMID: 205878

Abstract

A lymphocytic leukemia of probable monoclonal derivation, induced in a Syrian golden hamster by the oncogenic DNA simian virus 40, was adapted to grow in the allogeneic host either as leukemia or as lymphoma. The leukemia, which was produced by transplanting subcutaneously neoplastic lymphocytes that had circulated through and/or proliferated in lymph nodes and spleen, was characterized by dissemination with systemic manifestations and poor prognosis. The lymphoma, which was produced by transplanting subcutaneously neoplastic lymphocytes that had proliferated at subcutaneous sites of cell implantation, was characterized by localization and favorable prognosis. Evidence indicates that the tissue environment the neoplastic lymphocytes encounter during circulation and/or proliferation regulates their subsequent behavior in the intact host. Since the leukemic and lymphomatous forms of this animal model resemble very closely the analogous human lymphocytic neoplasms, it can serve as a means to elucidate the factors responsible for the differences in their behavior and to determine how these differences may influence prognosis and response to therapy.

Full text

PDF
2011

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aisenberg A. C. Malignant lymphoma. 1. N Engl J Med. 1973 Apr 26;288(17):883–890. doi: 10.1056/NEJM197304262881705. [DOI] [PubMed] [Google Scholar]
  2. Aisenberg A. C. Malignant lymphoma. 2. N Engl J Med. 1973 May 3;288(18):935–941. doi: 10.1056/NEJM197305032881804. [DOI] [PubMed] [Google Scholar]
  3. Aoshima M., Ishidate M., Jr Alteration of biologic behavior of a rat leukemia by different routes of passage. J Natl Cancer Inst. 1976 Apr;56(4):769–777. doi: 10.1093/jnci/56.4.769. [DOI] [PubMed] [Google Scholar]
  4. Bosmann H. B., Bieber G. F., Brown A. E., Case K. R., Gersten D. M., Kimmerer T. W., Lione A. Biochemical parameters correlated with tumour cell implantation. Nature. 1973 Dec 21;246(5434):487–489. doi: 10.1038/246487a0. [DOI] [PubMed] [Google Scholar]
  5. Coe J. E., Green I. B-cell origin of hamster lymphoid tumors induced by simian virus 40. J Natl Cancer Inst. 1975 Jan;54(1):269–270. doi: 10.1093/jnci/54.1.269. [DOI] [PubMed] [Google Scholar]
  6. Diamandopoulos G. T. Incidence, latency, and morphologic types of neoplasms induced by simian virus 40 inoculated intravenously into hamsters of three inbred strains and one outbred stock. J Natl Cancer Inst. 1978 Feb;60(2):445–449. doi: 10.1093/jnci/60.2.445. [DOI] [PubMed] [Google Scholar]
  7. Diamandopoulos G. T. Induction of lymphocytic leukemia, lymphosarcoma, reticulum cell sarcoma, and osteogenic sarcoma in the Syrian golden hamster by oncogenic DNA simian virus 40. J Natl Cancer Inst. 1973 May;50(5):1347–1365. doi: 10.1093/jnci/50.5.1347. [DOI] [PubMed] [Google Scholar]
  8. Diamandopoulos G. T., McLane M. F. Effect of host age, virus dose, and route of inoculation on tumor incidence, latency, and morphology in Syrian hamsters inoculated intravenously with oncogenic DNA simian virus 40. J Natl Cancer Inst. 1975 Aug;55(2):479–482. [PubMed] [Google Scholar]
  9. Enders J. F., Diamandopoulos G. T. A study of variation and progression in oncongenicity in an SV 40-transformed hamster heart cell line and its clones. Proc R Soc Lond B Biol Sci. 1969 Feb 25;171(1025):431–443. doi: 10.1098/rspb.1969.0004. [DOI] [PubMed] [Google Scholar]
  10. FEINLEIB M., MACMAHON B. Variation in the duration of survival of patients with the chronic leukemias. Blood. 1960 Mar;15:332–349. [PubMed] [Google Scholar]
  11. Fidler I. J. Biological behavior of malignant melanoma cells correlated to their survival in vivo. Cancer Res. 1975 Jan;35(1):218–224. [PubMed] [Google Scholar]
  12. Freeman C., Berg J. W., Cutler S. J. Occurrence and prognosis of extranodal lymphomas. Cancer. 1972 Jan;29(1):252–260. doi: 10.1002/1097-0142(197201)29:1<252::aid-cncr2820290138>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  13. Gershon R. K. A disquisition on suppressor T cells. Transplant Rev. 1975;26:170–185. doi: 10.1111/j.1600-065x.1975.tb00179.x. [DOI] [PubMed] [Google Scholar]
  14. Ishidate M., Jr, Aoshima M., Sakurai Y. Population changes of a rat leukemia by different routes of transplantation. J Natl Cancer Inst. 1974 Sep;53(3):773–781. doi: 10.1093/jnci/53.3.773. [DOI] [PubMed] [Google Scholar]
  15. Metcalf D., Moore M. A. Factors modifying stem cell proliferation of myelomonocytic leukemic cells in vitro and in vivo. J Natl Cancer Inst. 1970 Apr;44(4):801–808. [PubMed] [Google Scholar]
  16. Mukherji B., Yagoda A., Lee B. J., 3rd, Krakoff I. H. A clinical study of the natural history of lymphosarcoma and reticulum cell sarcoma. Eur J Cancer. 1974 Aug;10(8):497–505. doi: 10.1016/0014-2964(74)90073-5. [DOI] [PubMed] [Google Scholar]
  17. Norbury K. C. In vitro stimulation and inhibition of tumor cell growth mediated by different lymphoid cell populations. Cancer Res. 1977 May;37(5):1408–1415. [PubMed] [Google Scholar]
  18. POPE J. H., ROWE W. P. DETECTION OF SPECIFIC ANTIGEN IN SV40-TRANSFORMED CELLS BY IMMUNOFLUORESCENCE. J Exp Med. 1964 Aug 1;120:121–128. doi: 10.1084/jem.120.2.121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Prehn R. T. Immunostimulation of the lymphodependent phase of neoplastic growth. J Natl Cancer Inst. 1977 Oct;59(4):1043–1049. doi: 10.1093/jnci/59.4.1043. [DOI] [PubMed] [Google Scholar]
  20. ROSENBERG S. A., DIAMOND H. D., JASLOWITZ B., CRAVER L. F. Lymphosarcoma: a review of 1269 cases. Medicine (Baltimore) 1961 Feb;40:31–84. doi: 10.1097/00005792-196102000-00002. [DOI] [PubMed] [Google Scholar]
  21. Rausing A. Lymphatic leukemia and malignant lymphoma in the adult. A clinicopathologic study of their interrelationship. Acta Med Scand Suppl. 1976;595:1–270. [PubMed] [Google Scholar]
  22. TIVEY H. The prognosis for survival in chronic granulocytic and lymphocytic leukemia. Am J Roentgenol Radium Ther Nucl Med. 1954 Jul;72(1):68–93. [PubMed] [Google Scholar]
  23. Wang C. C. Malignant lymphoma of Waldeyer's ring. Radiology. 1969 May;92(6):1335–1339. doi: 10.1148/92.6.1335. [DOI] [PubMed] [Google Scholar]
  24. Woolner L. B., McConahey W. M., Beahrs O. H., Black B. M. Primary malignant lymphoma of the thyroid. Review of forty-six cases. Am J Surg. 1966 Apr;111(4):502–523. doi: 10.1016/0002-9610(66)90275-3. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES